Health Condition 1: C30-C39- Malignant neoplasms of respiratory and intrathoracic organs
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients with lesions involving the lung parenchyma, with or without extra-pulmonary extension (including pleural/chest wall/ mediastinal extension) amenable to percutaneous CT-guided biopsy.
Exclusion criteria
Exclusion criteria: 1. Patient refusal for consent. 2. Lung lesions deemed not amenable to safe percutaneous image-guided biopsy. 3. Patients with un-correctable coagulopathy, shock, cardiac failure, respiratory failure, sepsis 4. Pre-procedure pneumothorax, pneumomediastinum, surgical emphysema. 5. Pneumothorax that is developing during the procedure and before the withdrawal of the coaxial needle. 6. Patients with bronchopleural fistula.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To see whether the use of tract embolization agents has any effect of reduction in the incidence of pneumothorax post lung biopsy.Timepoint: The presence of pneumothorax will be detected using HRCT chest planned immediately post-procedure and after two hours. | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the rates of incidence of other major and minor complications associated with lung biopsy in between the three groups of study and to see whether the use of tract embolization agents has any effects on the reduction of those complications. Timepoint: Intra as well as immediate post-procedural complications will be assessed clinically and on HRCT chest planned immediately post-procedure and after two hours. Follow-up for delayed complications will be done after a week. | — |
Countries
India
Contacts
AIIMS BATHINDA